Chiraz Nasr Ben Ammar
Lotfi Kochbati
N. Lejri
K. Chaouache
Hatem Frikha
Mounir Besbes
S. Touati
M. Ben Abdallah
Mongi Maalej


Am: This study evaluated the prognostic value of the Para pharyngeal space involvement in nasopharyngeal carcinoma T 2 disease (UICC 1997 classification).
Methods : From January 1997 and December 2001; 32 patients with nasopharyngeal carcinoma were examined by CT scan and according to the 1997 International Union Against Cancer (UICC) staging system ,15 had stage T2a M0 (G1) and 17 T2bM0(G2). The median age was 47 years .The male to female ratio was 1.81 (G1); 4.3 (G2) . All patients were pathologically confirmed by biopsy from the nasopharynx as having UCNT in 100% (G1) and 94% (G2).The node
involvement was 52% for the G1(N2: 26%, N3: 26%) and 80% for the G2(N2: 47%, N3: 41%). Both neoadjuvant chemotherapy and radiotherapy were performed for advanced N disease and only radiotherapy for N0.
Results : Examination and CT scan were performed for the evaluation of the treatement. The completely clinical remission after chemotherapy was 12.5%(G1) and 53% (G2), partial remission was 25% (G1) and 35% (G2). The CT scan control wasn’t performed for all patients. The complete response was 69% (G1) and 53% (G2); partial response was 6% for both two groups. The median follow up was 79 months. Disease free survival rates were 70% for G1 (T2a) and 48% for G2 (T2b). Distant metastasis rates were 26% (G1) vs 6% (G2) and more likely in the presence of advanced N disease. Five years overall survival was 78% (G1) T2a vs 55%(G2) T2b.The N disease was correlated to metastasis as overall survival was 66.7% for N3 disease vs 85.7% for N0.
Conclusion : Parapharyngeal tumor involvement affects local and regional tumor failure. Subclassification of T2 disease into T2a/T2b should have an impact on treatment strategies.


Nasopharyngeal carcinoma, Parapharyngeal space, Staging, Prognosis



  1. Cheng SH, Tsai SY, Horng CF, Yen KL, Jian JJ, Chan KY, et al. A prognostic scoring system for locoregional control in nasopharyngeal carcinoma following conformal radiotherapy. Int J Radiat Oncol Biol Phys. 2006 ; 66: 992-1003.
  2. Chevallier JM. Anatomie ORL. Médecine-Sciences Flammarion. Edition Aout 2002.
  3. Chien CR, Chen SW, Hsieh CY, Liang JA, Yang SN, Huang CY et al. Retrospective comparison of the AJCC 5th edition classification for nasopharyngeal carcinoma with the AJCC 4th edition : an experience in Taiwan. Japanese Journal of Clinical Oncology 2001; 31: 363-69.
  4. Noel G, Dessard DB, Vignot S, Mazeron JJ. Les traitements des cancers
  5. du nasopharynx: revue de la littérature. Cancer/ Radiother 2002; 6 : 59-84.
  6. Perez CA, Devineni VR, Marcial-Vega V, Marks JE, Simpson JR, Kucik N. Carcinoma of the nasopharynx :factors affecting prognosis. Int J Radiat Oncol Biol Phys 1992; 23: 271-80.
  7. Rivera S, Keryer C, Busson P, Maingon P. Les carcinomes du nasopharynx : de la biologie à la clinique. Cancer/ Radiother 2005; 9: 55-68.
  8. Teo P, Kwan WH, Lee WY, Leung SF, Johnson PJ. Prognostic Factors determing survival subsequent to distant metastasis from nasopharyngeal carcinoma. Cancer 1996; 77: 2423-31.
  9. Charfi S, Khabir A, Ayadi L, Mseddi M, Makni H, Ghorbel A et al. Expression de c-Kit dans les carcinomes nasopharyngés nord africains, corrélations avec l'âge et LMP1. Cancer/ Radiother.2007.
  10. Cheng SH, Jian JJM, Tsai Stella, Chan KY, Yen LK, Chu NM et al. Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy. Int J Radiat Oncol Biol Phys. 1998; 41 : 755-62. 10. Tan E L, Looi L M, Sam C K. Evaluation of plasma Epstein-Barr virus DNA load as a prognostic marker for nasopharyngeal carcinoma. Singapore Med J 2006; 47: 803-7.
  11. Min H, Hong M, Ma J, Zhang E, Zheng Q, Zhang J et al. A new staging system for nasopharyngeal carcinoma in China. Int J Radiat Oncol Biol Phys 1994; 30: 1037-42.
  12. Sakata K, Hareyama M, Tamakwa M, Oouchi A, Sido M, Nagakura H et al. Prognostic factors of nasopharynx tumor investigated by MR imaging and the value of the MR imaging in the newly published TNM staging. Int J Radiat Oncol Biol Phys 1999; 43: 273-78.
  13. Gao JM, Zeng YX, Cui NJ, Lu TX, Zhao C, Xia YFet al. Staging 915 cases of nasopharyngeal carcinoma after simple radical radiotherapy (Part II) Checkout of AJCC/UICC staging system (1997). Ai Zheng 2006; 25: 257- 63.
  14. Marcy PY, Zhu Y, Bensadoun RJ. Volumes cibles en radiothérapie des tumeurs de la tête et du cou. Radiothérapie conformationnelle avec modulation d'intensité (RCIM) des carcinomes du cavum : aspects pratiques de la délination des volumes cibles et des organes critiques. Cancer/ Radiother.2005; 9: 240-50.
  15. Olmi P , Fallai C , Colagrande S, Giannardi G. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography. Int J Radiat Oncol Biol phy 1995;32: 795-800.
  16. Chua DTT, Sham JST, Kwong DLW, Choy DTK, Au GKH, Wu PM. Prognostic value of parapharyngeal extension of nasopharyngeal carcinoma. A significant factor in local control and distant metastasis. Cancer 1996; 78:202-10.
  17. Sham JST, Choy D. Prognostic value of parapharyngeal extension of nasopharyngeal carcinoma on local control andshort term survival. Head Neck 1991; 13: 298-310.
  18. Xiao GL, Gao L, Zhen XG. Prognostic influence of parapharyngeal space involvement in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2002; 52 : 957-63.
  19. Teo P, Lee WY, Yu P: The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiotherapy and Oncology 1996; 39: 209-21.
  20. ALAmro A, Al Rajhi N, Khafaga Y, Memon M, Al Hebshi A, El Enbabi A et al. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2005; 62 : 508-13.
  21. Okita J, Hatta C, Terada T, Saeki N, Ogasawara H, Kakibuchi M et al. Concurrent chemo-radiotherapy for nasopharyngeal carcinoma. Auris Nasus Larynx.2004 ; 31 : 43-7.
  22. Pignon JP, Baujat B, Bourhis J. Apport des méta-analyses sur données individuelles au traitement des cancers ORL. Cancer/ Radiother. 2005; 9: 31-6.
  23. Wu S, Xie C, Jin X, Zhang P. Simultaneous modulated accelerated radiation therapy in the treatment of nasopharyngeal cancer : a local centre's experience. Int J Radiat Oncol Biol Phys. 2006; 66 : S40-46.
  24. Lu H, Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer treatment review.2007